RxDoctor Payments Data
★ My doctorsLook up a doctor →

George Geils

Hematology & Oncology · Charleston, SCNPI 1285692855

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 92.5% of the total across 322 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 54 manufacturers, the largest accounting for just 11.3% — the pattern of someone who eats at a lot of different presentations.

$6,628in general payments, 2019–2025

Across 322 payments — averaging $20.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$750
  • Pfizer$687
  • Gilead$459
  • Novartis$433
  • Takeda Pharmaceuticals U.S.A., Inc.$426
  • Regeneron Healthcare Solutions, Inc.$356
  • plus $4K from 48 others
$146,550in research payments, 2019–2025

Across 33 payments — averaging $4440.91 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Otsuka Pharmaceutical Co., Ltd.$120K
  • Beigene, Ltd.$17K
  • TG Therapeutics, Inc.$8K
  • Janssen Research & Development, LLC$2K

What the payments were for

  • Speaking & faculty fees$5008%
  • Food & beverage$6,12892%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Johnson & Johnson18$750
Pfizer42$687
Gilead(2 entities)15$459
Novartis25$433
Takeda Pharmaceuticals U.S.A., Inc.19$426
Regeneron Healthcare Solutions, Inc.19$356
GSK18$286
Incyte Corporation11$247
AstraZeneca(2 entities)13$237
Bristol Myers Squibb11$213
E.r. Squibb & Sons, L.L.C.11$186
Taiho Oncology, Inc.9$178
Genentech USA, Inc.9$153
Seagen Inc.9$152
Merck9$142
Boehringer Ingelheim5$137
Eisai Inc.6$122
Lilly USA, LLC5$111
Amgen6$101
EMD Serono, Inc.5$89
AbbVie4$85
Adaptive Biotechnologies Corporation3$82
Stryker1$63
Puma Biotechnology, Inc.3$59
Sanofi2$54
Dova Pharmaceuticals3$53
Daiichi Sankyo Inc.2$52
Rigel Pharmaceuticals, Inc.3$49
Pharmacyclics LLC, An Abbvie Company3$47
Syndax Pharmaceuticals, Inc.2$41
Stemline Therapeutics Inc.2$41
Jazz Pharmaceuticals Inc.2$40
Immunogen, Inc.2$40
Epizyme, Inc.3$39
Astellas Pharma US Inc2$28
Tesaro, Inc.2$28
Acrotech Biopharma Inc.1$27
CSL Behring1$26
Myovant Sciences Inc.1$26
Ipsen Biopharmaceuticals, Inc1$24
Azurity Pharmaceuticals, Inc.1$23
Karyopharm Therapeutics Inc.1$21
Shield Therapeutics Inc1$21
Medtronic1$21
Kyowa Kirin, Inc.1$20
Pharmacosmos Therapeutics Inc.1$20
G1 Therapeutics, Inc.1$19
Deciphera Pharmaceuticals Inc.1$18
Spectrum Pharmaceuticals Inc.1$18
Caris MPI, Inc.1$18
Pharmaessentia USA Corporation1$17
Sanofi-aventis U.S. LLC1$17
Blue Earth Diagnostics1$16
Mylan Institutional Inc.1$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,628 in reported general payments places this provider in the 60th percentile of 166 hematology & oncology providers in South Carolina.

See all hematology & oncology providers in South Carolina →

Other hematology & oncology in Charleston

See the full list for South Carolina →

Where these figures come from

Is this you, or does something look wrong? →